BIM-018 is a synthetic cannabinoid that is the benzimidazole analog of JWH-018. It is presumed to be a potent agonist of the CB2 receptor and has been sold online as a designer drug.[1]

BIM-018
Legal status
Legal status
Identifiers
  • 2-(naphthalene-1-carbonyl)-1-pentyl-1H-1,3-benzodiazole
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC23H22N2O
Molar mass342.442 g·mol−1
3D model (JSmol)
  • CCCCCn1c2ccccc2nc1C(=O)c1cccc2c1cccc2
  • InChI=1S/C23H22N2O/c1-2-3-8-16-25-21-15-7-6-14-20(21)24-23(25)22(26)19-13-9-11-17-10-4-5-12-18(17)19/h4-7,9-15H,2-3,8,16H2,1H3
  • Key:ZJWSSWFQIOEVCU-UHFFFAOYSA-N

Related benzimidazole derivatives have been reported to be highly selective agonists for the CB2 receptor.[2]

See also

edit

References

edit
  1. ^ "BIM-018". Cayman Chemical. Retrieved 24 July 2015.
  2. ^ Pagé D, Balaux E, Boisvert L, Liu Z, Milburn C, Tremblay M, et al. (July 2008). "Novel benzimidazole derivatives as selective CB2 agonists". Bioorganic & Medicinal Chemistry Letters. 18 (13): 3695–700. doi:10.1016/j.bmcl.2008.05.073. PMID 18522867.